Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Linder

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Clinical Chemistry|August 28, 2004
Fine-tuning pharmacogenetics: paradigm for linking laboratory results to clinical actionRoland Valdes, Mark W Linder
Clinics in Laboratory Medicine|August 13, 2016
Extracellular Vesicles Move Toward Use in Clinical LaboratoriesLindsay N Strotman, Mark W Linder
Pharmacogenomics|July 2, 2003
What is next in pharmacogenomics? Translating it to clinical practiceRoland Valdes, Mark W Linder, Saeed A Jortani
Journal of Cardiothoracic and Vascular Anesthesia|July 3, 2004
Pharmacogenetics as related to the practice of cardiothoracic and vascular anesthesiaBonny L Bukaveckas, Roland Valdes, Mark W Linder
Critical Reviews in Clinical Laboratory Sciences|November 5, 2019
Polypharmacy: a healthcare conundrum with a pharmacogenetic solutionCierra N Sharp, Mark W Linder, Roland Valdes
Annals of Clinical and Laboratory Science|July 26, 2013
Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypesLori M Millner, Mark W Linder, Roland Valdes
American Journal of Clinical Pathology|May 6, 2025
Evaluation of turnaround times and performance of in-house ChromaCode high-definition PCR compared to send-out next-generation sequencing in non-small cell lung cancerNathan C Hogarth, Mustafa Al-Kawaaz, Mark W Linder
Therapeutic Drug Monitoring|May 3, 2012
A diagnostic informatics approach for stratifying risk outcome based on combined genotype effectsLu Yang, Roland Valdes, Dirk Taubert, et al.
Clinics in Laboratory Medicine|August 13, 2016
Clinical Utility and Economic Impact of CYP2D6 GenotypingKristen K Reynolds, Beth A McNally, Mark W Linder
Personalized Medicine|May 26, 2018
Individualizing warfarin therapyKristen K Reynolds, Roland Valdes, Bronwyn R Hartung, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical Chemistry|August 28, 2004
Fine-tuning pharmacogenetics: paradigm for linking laboratory results to clinical actionRoland Valdes, Mark W Linder
Clinics in Laboratory Medicine|August 13, 2016
Extracellular Vesicles Move Toward Use in Clinical LaboratoriesLindsay N Strotman, Mark W Linder
Pharmacogenomics|July 2, 2003
What is next in pharmacogenomics? Translating it to clinical practiceRoland Valdes, Mark W Linder, Saeed A Jortani
Journal of Cardiothoracic and Vascular Anesthesia|July 3, 2004
Pharmacogenetics as related to the practice of cardiothoracic and vascular anesthesiaBonny L Bukaveckas, Roland Valdes, Mark W Linder
Critical Reviews in Clinical Laboratory Sciences|November 5, 2019
Polypharmacy: a healthcare conundrum with a pharmacogenetic solutionCierra N Sharp, Mark W Linder, Roland Valdes
Annals of Clinical and Laboratory Science|July 26, 2013
Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypesLori M Millner, Mark W Linder, Roland Valdes
American Journal of Clinical Pathology|May 6, 2025
Evaluation of turnaround times and performance of in-house ChromaCode high-definition PCR compared to send-out next-generation sequencing in non-small cell lung cancerNathan C Hogarth, Mustafa Al-Kawaaz, Mark W Linder
Therapeutic Drug Monitoring|May 3, 2012
A diagnostic informatics approach for stratifying risk outcome based on combined genotype effectsLu Yang, Roland Valdes, Dirk Taubert, et al.
Clinics in Laboratory Medicine|August 13, 2016
Clinical Utility and Economic Impact of CYP2D6 GenotypingKristen K Reynolds, Beth A McNally, Mark W Linder
Personalized Medicine|May 26, 2018
Individualizing warfarin therapyKristen K Reynolds, Roland Valdes, Bronwyn R Hartung, et al.
Pageof 4